Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Yan Shen Kee, Chee Kuan Wong, Muhammad Anis Abdul Aziz, Mohd Idzwan Zakaria, Fatimah Mohd Shaarif, Kee Seong Ng, Chong Kin Liam, Yong Kek Pang & Ee Ming Khoo. (2023) 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2623-2631.
Read now
Read now
John R Hurst, Mohd Kashif Siddiqui, Barinder Singh, Precil Varghese, Ulf Holmgren & Enrico de Nigris. (2021) A Systematic Literature Review of the Humanistic Burden of COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1303-1314.
Read now
Read now
Stéphanie Cousse, André Gillibert, Mathieu Salaün, Luc Thiberville, Antoine Cuvelier & Maxime Patout. (2019) Efficacy of a home discharge care bundle after acute exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 289-296.
Read now
Read now
Nurdan Kokturk, Mehmet Polatli, I Kivilcim Oguzulgen, Sarfraz Saleemi, Mohammed Al Ghobain, Javed Khan, Adam Doble, Luqman Tariq, Fayaz Aziz & Abdelkader El Hasnaoui. (2018) Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1377-1388.
Read now
Read now
David MG Halpin, Marc Miravitlles, Norbert Metzdorf & Bartolomé Celli. (2017) Impact and prevention of severe exacerbations of COPD: a review of the evidence. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2891-2908.
Read now
Read now
Anna Garner, Matthew Hodson, Georgios Ketsetzis, Laurence Pulle, Janelle Yorke & Angshu Bhowmik. (2017) An analysis of the economic and patient outcome impact of an integrated COPD service in east London. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1653-1662.
Read now
Read now
Bo Ding, Mark Small, Gina Bergström & Ulf Holmgren. (2017) COPD symptom burden: impact on health care resource utilization, and work and activity impairment. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 677-689.
Read now
Read now
Oskar Eklund, Faraz Afzal, Fredrik Borgström, Jason Flavin, Andrew Ternouth, Maria Eugenia Ojanguren, Carlos Crespo & Mike Baldwin. (2016) Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK. ClinicoEconomics and Outcomes Research 8, pages 243-252.
Read now
Read now
Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus Vogelmeier, Nadine Lossi, Claudia Mailänder & Heinrich Worth. (2016) A year in the life of German patients with COPD: the DACCORD observational study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1639-1646.
Read now
Read now
Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen & Michiel E. H. Hemels. (2015) Utilities for asthma and COPD according to category of severity: a comprehensive literature review. Journal of Medical Economics 18:7, pages 550-563.
Read now
Read now
Articles from other publishers (32)
Sunil K. Chhabra & Devi Jyoti Dash. (2022) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Causes and Impacts. The Indian Journal of Chest Diseases and Allied Sciences 56:2, pages 93-104.
Crossref
Crossref
A. Machado, M. Barusso, J. De Brandt, K. Quadflieg, S. Haesevoets, M. Daenen, M. Thomeer, D. Ruttens, A. Marques & C. Burtin. (2022) Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review. Pulmonology.
Crossref
Crossref
Konstantinos Gourgoulianis, Alessandro Ruggieri, Alessandra del Vecchio, Fabrizio Calisti, Alessandro Comandini, Giovanna Esposito, Giorgio Di Loreto & Nikolaos Tzanakis. (2021) Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study. Canadian Respiratory Journal 2021, pages 1-11.
Crossref
Crossref
Juan Huang, Yongjun Bian, Yuanchen Zhao, Zaiyan Jin, Li Liu & Guangxi Li. (2021) The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study. Journal of Affective Disorders 281, pages 147-152.
Crossref
Crossref
Tim Luckett, Aljon San Martin, David C Currow, Miriam J Johnson, Matilda MM Barnes-Harris & Jane L Phillips. (2020) A systematic review and meta-analysis of studies comparing burden from lung cancer and chronic obstructive pulmonary disease. Palliative Medicine 34:10, pages 1291-1304.
Crossref
Crossref
Ann‐Jean C. C. Beck, Valesca P. Retèl, Glenn Bunting, Rosh K. V. Sethi, Daniel G. Deschler, Michiel W. M. Brekel & Wim H. Harten. (2020)
Cost‐effectiveness analysis of using the heat and moisture exchangers compared with alternative stoma covers in laryngectomy rehabilitation:
US
perspective
. Head & Neck 42:12, pages 3720-3734.
Crossref
Crossref
Randy Sorge & Peter DeBlieux. (2020) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Primer for Emergency Physicians. The Journal of Emergency Medicine 59:5, pages 643-659.
Crossref
Crossref
Soo Kyung Park. (2020) Changes in symptoms and health-related quality of life in patients with exacerbated chronic obstructive pulmonary disease. Applied Nursing Research 54, pages 151278.
Crossref
Crossref
John R. Hurst, Neil Skolnik, Gerald J. Hansen, Antonio Anzueto, Gavin C. Donaldson, Mark T. Dransfield & Precil Varghese. (2020) Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. European Journal of Internal Medicine 73, pages 1-6.
Crossref
Crossref
Suzanne G Bollmeier & Aaron P Hartmann. (2020) Management of chronic obstructive pulmonary disease: A review focusing on exacerbations. American Journal of Health-System Pharmacy 77:4, pages 259-268.
Crossref
Crossref
Claudio Micheletto & Alice Sparacino. (2019) Triple Therapy in COPD. Current Respiratory Medicine Reviews 15:2, pages 102-111.
Crossref
Crossref
Susan E. Yount, Charles Atwood, James Donohue, Ron D. Hays, Debra Irwin, Nancy Kline Leidy, Honghu Liu, Karen L. Spritzer & Darren A. DeWalt. (2019) Responsiveness of PROMIS® to change in chronic obstructive pulmonary disease. Journal of Patient-Reported Outcomes 3:1.
Crossref
Crossref
Elizabeth Golembiewski, Katie S Allen, Amber M Blackmon, Rachel J Hinrichs & Joshua R Vest. (2019) Combining Nonclinical Determinants of Health and Clinical Data for Research and Evaluation: Rapid Review. JMIR Public Health and Surveillance 5:4, pages e12846.
Crossref
Crossref
Catherine Le Berre, Laurent Peyrin-Biroulet, Anne Buisson, Alain Olympie, Marie-Hélène Ravel, Christina Bienenfeld & Florent Gonzalez. (2019) Impact of inflammatory bowel diseases on working life: A French nationwide survey. Digestive and Liver Disease 51:7, pages 961-966.
Crossref
Crossref
Yuan Zhang, Rebecca L. Morgan, Pablo Alonso-Coello, Wojtek Wiercioch, Małgorzata M. Bała, Rafał R. Jaeschke, Krzysztof Styczeń, Hector Pardo-Hernandez, Anna Selva, Housne Ara Begum, Gian Paolo Morgano, Marcin Waligóra, Arnav Agarwal, Matthew Ventresca, Karolina Strzebońska, Mateusz T. Wasylewski, Lídia Blanco-Silvente, Janna-Lina Kerth, Mengxiao Wang, Yuqing Zhang, Saiprasad Narsingam, Yutong Fei, Gordon Guyatt & Holger J. Schünemann. (2018) A systematic review of how patients value COPD outcomes. European Respiratory Journal 52:1, pages 1800222.
Crossref
Crossref
Sun Hye Shin, Jihwan Park, Juhee Cho, Don D. Sin, Hyun Lee & Hye Yun Park. (2018) Severity of Airflow Obstruction and Work Loss in a Nationwide Population of Working Age. Scientific Reports 8:1.
Crossref
Crossref
K K Rai, P Adab, J G Ayres & R E Jordan. (2018) Systematic review: chronic obstructive pulmonary disease and work-related outcomes. Occupational Medicine 68:2, pages 99-108.
Crossref
Crossref
Wouter Poortinga, Sarah E Rodgers, Ronan A Lyons, Pippa Anderson, Chris Tweed, Charlotte Grey, Shiyu Jiang, Rhodri Johnson, Alan Watkins & Thomas G Winfield. (2018) The health impacts of energy performance investments in low-income areas: a mixed-methods approach. Public Health Research 6:5, pages 1-182.
Crossref
Crossref
Alexandra Strassmann, Anja Frei, Sarah R. Haile, Gerben ter Riet & Milo A. Puhan. (2017) Commonly Used Patient-Reported Outcomes Do Not Improve Prediction of COPD Exacerbations. Chest 152:6, pages 1179-1187.
Crossref
Crossref
Bartłomiej K. Sołtysik, Łukasz Kroc, Małgorzata Pigłowska, Agnieszka Guligowska, Janusz Śmigielski & Tomasz Kostka. (2017) An Evaluation of the Work and Life Conditions and the Quality of Life in 60 to 65 Year-Old White-Collar Employees, Manual Workers, and Unemployed Controls. Journal of Occupational & Environmental Medicine 59:5, pages 461-466.
Crossref
Crossref
Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Dave Singh. (2017) Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial. The Lancet 389:10082, pages 1919-1929.
Crossref
Crossref
P.R. Burgel. (2017) Quel est l’impact d’une exacerbation de BPCO et de la répétition des exacerbations sur l’évolution de la maladie ?. Revue des Maladies Respiratoires 34:4, pages 331-337.
Crossref
Crossref
Paul S. J. Miller, Harry Hill & Fredrik L. Andersson. (2016) Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases. PharmacoEconomics 34:12, pages 1277-1297.
Crossref
Crossref
Dave Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri & Jørgen Vestbo. (2016) Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial. The Lancet 388:10048, pages 963-973.
Crossref
Crossref
Lucia Dignani, Andrea Toccaceli, Carla Lucertini, Cristina Petrucci & Loreto Lancia. (2015) Sleep and Quality of Life in People With COPD. Clinical Nursing Research 25:4, pages 432-447.
Crossref
Crossref
Amol D. Dhamane, Edward A. Witt & Jun Su. (2016) Associations Between COPD Severity and Work Productivity, Health-Related Quality of Life, and Health Care Resource Use. Journal of Occupational & Environmental Medicine 58:6, pages e191-e197.
Crossref
Crossref
Oskar Eklund, Faraz Afzal & Fredrik Borgström. (2015) Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Crossref
Janine Dretzke, Deirdre Blissett, Chirag Dave, Rahul Mukherjee, Malcolm Price, Sue Bayliss, Xiaoying Wu, Rachel Jordan, Sue Jowett, Alice M Turner & David Moore. (2015) The cost-effectiveness of domiciliary non-invasive ventilation in patients with end-stage chronic obstructive pulmonary disease: a systematic review and economic evaluation. Health Technology Assessment 19:81, pages 1-246.
Crossref
Crossref
Karly P. Garnock-Jones. (2015) Roflumilast: A Review in COPD. Drugs 75:14, pages 1645-1656.
Crossref
Crossref
Massimo Guerriero, Marco Caminati, Giovanni Viegi, Gianenrico Senna, Giancarlo Cesana & Carlo Pomari. (2015) COPD prevalence in a north-eastern Italian general population. Respiratory Medicine 109:8, pages 1040-1047.
Crossref
Crossref
Philip Harber. (2015) Respiratory disability and impairment. Current Opinion in Pulmonary Medicine 21:2, pages 201-207.
Crossref
Crossref
R. Rubinsztajn, T. Przybyłowski, M. Maskey-Warzęchowska, K. Karwat & R. Chazan. 2016. Pathophysiology of Respiration. Pathophysiology of Respiration
69
74
.